feed,title,long_url,short_url
SeekingAlpha,Bellicum plunges 49% after ending trials for CAR-T candidates,https://seekingalpha.com/news/3947664,
SeekingAlpha,Compass Therapeutics GAAP EPS of -$0.10,https://seekingalpha.com/news/3947663,
SeekingAlpha,Halozyme sees no impact on royalties after EU body revokes J&J's Darzalex patent,https://seekingalpha.com/news/3947661,
SeekingAlpha,Prelude Therapeutics GAAP EPS of $2.44,https://seekingalpha.com/news/3947662,
